Fluticasone Propionate Chemical Structure (Fluticasone Propionate Diskus Spl Graphic 01)
Fluticasone Propionate Powder, Metered
Product Images NDC 50090-7962
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 50090-7962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Fluticasone Propionate Diskus Spl Graphic 02)
This is a comparison between Fluticasone Propionate DISKUS 100 mcg twice daily and placebo in terms of their effect on lung function. The baseline Forced Expiratory Volume (FEV) for Fluticasone Propionate was 2.60 L and for placebo was 2.62 L. The chart displays the percentage change in FEV over time, with measurements taken at 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 endpoints. The data shows the potential impact on lung function for the two treatments.*
Figure 2 (Fluticasone Propionate Diskus Spl Graphic 03)
This text provides information on a study comparing the effectiveness of Fluticasone Propionate DISKUS 100 mcg twice daily with a placebo, based on the baseline FEV1 values. The study may be evaluating the percentage change from the baseline FEV1 values at different time points up to the endpoint.*
Figure 3 (Fluticasone Propionate Diskus Spl Graphic 04)
Fluticasone Propionate DISKUS 250 mcg twice daily and Placebo were compared based on their effects on FEV (Forced Expiratory Volume). The baseline FEV values were 2.44 L for Fluticasone Propionate and 2.46 L for Placebo. The graph displayed the percentage change from the baseline in FEV over the treatment period up to the endpoint.*
Figure 4 (Fluticasone Propionate Diskus Spl Graphic 05)
This text provides information about a study comparing Fluticasone Propionate DISKUS 500 mcg twice daily with a placebo treatment, with baseline FEV values recorded for each group. The text also presents a chart showing the percentage change from baseline in FEV over the endpoint measurement points.*
Figure A (Fluticasone Propionate Diskus Spl Graphic 06)
This is a list of parts that may belong to a specific item or product. The "Outer Case" is likely the exterior shell or cover, while the "Counter" could be a display or numerical counting mechanism. The "Mouthpiece" is a component that connects to the item for specific functionality, such as a microphone or instrument mouthpiece. The "Thumb Grip" is probably a part designed for easy handling or grip with the thumb. Lastly, the "Lever" might be a movable part used to control or activate the item.*
Figure B (Fluticasone Propionate Diskus Spl Graphic 07)
Figure C (Fluticasone Propionate Diskus Spl Graphic 08)
Figure D (Fluticasone Propionate Diskus Spl Graphic 09)
Figure E (Fluticasone Propionate Diskus Spl Graphic 10)
Figure F (Fluticasone Propionate Diskus Spl Graphic 11)
Figure G (Fluticasone Propionate Diskus Spl Graphic 12)
Figure H (Fluticasone Propionate Diskus Spl Graphic 13)
Label Image (Lbl500907962)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
